GeneralConnection.com ➔ Dictionary
Dictionary Search

sle

Synonyms

Noun

1. systemic lupus erythematosus

2. SLE, disseminated lupus erythematosus, lupus

Usage
CASE: CAR T-Cell Therapy for Lupus Patient With Kidney Involvement - Cleveland Clinic
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis - BioSpace
Anifrolumab Shows Real-World Promise in Systemic Lupus Erythematosus - European Medical Journal
Systemic Lupus Erythematosus: Diagnosis and Treatment - American Academy Of Family Physicians | AAFP
Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial - Nature
SLE: four trials to watch in 2026 - Clinical Trials Arena
Saphnelo approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus - AstraZeneca
Factors Associated With Fatigue in Systemic Lupus Erythematosus Identified - Docwire News
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus - The New England Journal of Medicine
SLE program offers glimpse of West Point’s immense possibilities for prospective high school students - United States Military Academy West Point
Positioning rituximab in the therapeutic strategies for SLE - Frontiers
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial - The Lancet
Phase III Study Shows Positive Results for Gazyva® in Systemic Lupus Erythematosus - Lupus Foundation of America
Germinal-centre and extrafollicular B cell pathways in systemic lupus erythematosus - Nature
Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus - AstraZeneca
Alterations in peripheral blood B cell subsets and their clinical significance in systemic lupus erythematosus - Nature
Saphnelo self-administration TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in systemic lupus erythematosus disease activity - AstraZeneca
Mechanistic link uncovered between EBV infection and SLE - Nature
Prasugrel inhibits TLR7-driven autoimmunity in systemic lupus erythematosus by acetylating cGAS - Nature
Single-cell profiling unveils nephritis-related circulating immunological signatures in systemic lupus erythematosus patients - Nature
Immune-Mediated Demyelinating Polyradiculoneuropathies Linked to Systemic Lupus Erythematosus (SLE): A Systematic Review of Clinical Features, Diagnostic and Treatment Modalities - Cureus
Update: Gazyva® significantly reduces disease activity in adults with systemic lupus erythematosus - Lupus Foundation of America
Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus - Nature
FDA Accepts Supplemental Biologics Application for Gazyva® in Systemic Lupus Erythematosus - Lupus Foundation of America
Complement and autoantibody levels under anifrolumab therapy in SLE: implications for clinical practice - Frontiers
EBV and SLE: causal or concurrence? - The Lancet
Loss-of-function mutations in PLD4 lead to systemic lupus erythematosus - Nature
Effects of telitacicept and belimumab on systemic lupus erythematosus: a systematic review and meta-analysis - Nature
Acute Pericarditis: An Isolated Initial Manifestation of Systemic Lupus Erythematosus (SLE) - Cureus
New Study Finds Potential Biomarker Linking Fat Imbalance to Systemic Lupus Erythematosus - Lupus Foundation of America
Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial - Nature
Saphnelo approved in the EU for subcutaneous self-administration as a new pre-filled pen for systemic lupus erythematosus - AstraZeneca
Study reveals link between cytomegalovirus infection and systemic lupus erythematosus - Lupus Foundation of America
A Case of Systemic Lupus Erythematosus Initially Presenting With Generalized Lymphadenopathy: A Diagnostic Challenge - Cureus
Belimumab Monotherapy Matches Combination Therapy in Systemic Lupus Erythematosus - Medscape
Two Cases of Systemic Lupus Erythematosus With Castleman Disease - Cureus
Cost-utility analysis of telitacicept versus belimumab in the treatment of systemic lupus erythematosus in China - Frontiers
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025 - Biogen
Clinical and Immunological Profiles With Treatment Patterns in Systemic Lupus Erythematosus Patients in the Eastern Part of India: A Retrospective, Hospital-Based, Cross-Sectional Study - Cureus
Insights into the pathogenesis of childhood-onset SLE in the past decade - Nature
New study finds link between Epstein-Barr virus and the development of Systemic Lupus Erythematosus - Lupus Foundation of America
Case Report: Telitacicept in the treatment of systemic lupus erythematosus complicated by acquired hemophilia A - Frontiers
Systemic Lupus Erythematosus: Emerging Insights into Diagnosis, Treatment, and Prognosis - Science Partner Journals
The microbiota-systemic lupus erythematosus axis: mechanisms, diagnostics, and therapeutic frontiers - Frontiers
Lectin pathway components and autoantibodies as novel immunological biomarkers in systemic lupus erythematosus (SLE) patients from Western India - Nature
Systemic Lupus Erythematosus (SLE) Complicated by Human Immunodeficiency Virus (HIV): A Rare and Challenging Association - Cureus
Lupus Enteritis: An Unusual Flare of Systemic Lupus Erythematosus - Cureus
FDA Approves SAPHNELO Self-Administration for Treatment of Systemic Lupus Erythematosus - Lupus Foundation of America
Immunopathogenesis of accelerated atherosclerosis in systemic lupus erythematosus: from innate and adaptive dysregulation to clinical implications - Frontiers
Saphnelo self-administration TULIP-SC Phase III trial meets primary endpoint in patients with systemic lupus erythematosus based on an interim analysis - AstraZeneca
Disease activity maintenance and prevalence in people with systemic lupus erythematosus with clinically active disease - Lupus Foundation of America
First-of-Its-Kind Lupus Treatment Significantly Reduces Symptoms in Mice - ScienceAlert
Azathioprine Exposure Associated with Liver Condition in Systemic Lupus Erythematosus Pregnancies - Lupus Foundation of America
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial - Nature
Applications of artificial intelligence in systemic lupus erythematosus: integrating multi-omics data for precision medicine - Frontiers
CAR-T Cell Therapy Induces Durable Remission in SLE - European Medical Journal
New research links discrimination to worse Systemic Lupus Erythematosus-related symptoms and mental health outcomes - Lupus Foundation of America
Neuropsychiatric Systemic Lupus Erythematosus Diagnosed Following Treatment Initiated for Acute Encephalitis - Cureus
Aurinia Unchanged on Unveiling Lupus Treatment - Baystreet.ca
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial - Nature
Blood Test Reveals Risks in Antiphospholipid Syndrome, SLE - Medscape
Advances in understanding the Th17/Treg balance in systemic lupus erythematosus: implications for treatment and management - Frontiers
Journal of Hepato-Biliary-Pancreatic Sciences | JSHBPS Pancreas Journal - Wiley Online Library
Bullous Systemic Lupus Erythematosus as a Marker of Treatment-Refractory Systemic Disease: A Case Report - Cureus
Lupus-Associated Knee Pain: An Atypical Presentation of Systemic Lupus Erythematosus in a Young Male - Cureus
Systemic Lupus Erythematosus Complicated by Spontaneous Splenic Rupture - Cureus
New study finds certain blood-derived biomarkers can identify Systemic Lupus Erythematosus disease activity - Lupus Foundation of America
Calcinosis Cutis in a Patient With Systemic Lupus Erythematosus: A Case Report - Cureus
Systemic Lupus Erythematosus-Specific Risk Factors Linked to Osteoporosis and Bone Fracture Development - Lupus Foundation of America
Tuberculosis in patients with systemic lupus erythematosus - Frontiers
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis - The Norfolk Daily News
Autoimmune myelofibrosis and systemic lupus erythematosus: a case report - Elsevier
Kikuchi-Fujimoto Disease Associated With Systemic Lupus Erythematosus Presenting With Prominent Cutaneous Manifestations: A Case Report - Cureus
Crohn's disease in patients with systemic lupus erythematosus - Elsevier
New study finds systemic lupus erythematosus associated with adverse outcomes in right heart failure - Lupus Foundation of America
Advances in the treatment of systemic lupus erythematosus - Nature
Systemic lupus erythematosus, a disease conditioned by the environment - Elsevier
A practical perspective on gastrointestinal manifestations of systemic lupus erythematosus - Elsevier
Systemic lupus erythematosus and neurologic involvement: A heterogeneous manifestation - Elsevier
Unraveling the Complexity: A Case of Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, and Autoimmune Cholangitis - Cureus
Bilateral Retinal Vasculitis in Systemic Lupus Erythematosus: A Case Series of Three Patients - Cureus
Opportunities and limitations of B cell depletion approaches in SLE - Nature
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus - Nature
Neuropsychiatric Symptoms in SLE: Diagnosis and Treatment - Rheumatology Advisor
The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus - Nature
Worse cardiovascular and renal outcome in male SLE patients - Nature
An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management - Cureus
SLE Q1 2026 Earnings: EPS Beats Estimates Despite Revenue Challenges - Net Income Trends - dars.gov.et
He discovered the mechanisms behind SLE at an early stage - Uppsala universitet
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus - The New England Journal of Medicine
Systemic lupus erythematosus - The Lancet
The 330 risk loci known for systemic lupus erythematosus (SLE): a review - Frontiers
Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity - Biogen
TASL has a key role in SLE - Nature
Advances in natural products and antibody drugs for SLE: new therapeutic ideas - Frontiers
Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce - Nature
Disease activity assessment in systemic lupus erythematosus - Frontiers
Evaluation of disease activity in systemic lupus erythematosus using standard deviation of lymphocyte volume combined with red blood cell count and lymphocyte percentage - Nature
Emerging concepts of type I interferons in SLE pathogenesis and therapy - Nature
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I) - The Lancet
Foreign Language Equivalents
Foreign Language Equivalents of 'sle'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
ske,   dle,   slle,   se,   ale,   le,   s;e,   slw,   sel,   sl,   slee,   lse,   slr,   ssle
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z